WASHINGTON, June 20, 2016 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced that
Mihael H. Polymeropoulos, M.D.,
Vanda's President and CEO, will deliver a corporate presentation at
the JMP Securities Life Sciences Conference in New York City on Tuesday, June 21, 2016 at 3:30 p.m. Eastern Time.
The presentation at the JMP Securities Life Sciences Conference
will be available live on Vanda's corporate website, where it also
will be archived for 30 days. To access the presentation, go
to Vanda's website at www.vandapharma.com and click on the
Presentations tab on the Investor Relations page. Please
connect to the website several minutes prior to the start of the
live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a specialty
pharmaceutical company focused on the development and
commercialization of novel therapies to address high unmet medical
needs and improve the lives of patients. For more on Vanda, please
visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-present-at-the-jmp-securities-life-sciences-conference-300287325.html
SOURCE Vanda Pharmaceuticals Inc.